January 31, 2018

Monthly Publications Mixtape

Here is a selection of recent collaborative publications involving DF/HCC authors for your reading pleasure.

Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.
Cell. 2018 Jan 11.
Hoggatt J (MGH), Singh P, Tate TA, Chou BK, Datari SR, Fukuda S, Liu L, Kharchenko PV (HMS), Schajnovitz A, Baryawno N, Mercier FE, Boyer J, Gardner J, Morrow DM, Scadden DT (MGH), Pelus LM.
PMID: 29224778

Fiber Intake and Survival After Colorectal Cancer Diagnosis.
JAMA Oncol. 2018 Jan 1.
Song M (MGH), Wu K (HSPH), Meyerhardt JA (DFCI), Ogino S (DFCI), Wang M (HSPH), Fuchs CS, Giovannucci EL (HSPH), Chan AT (MGH).
PMCID: PMC5776713

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. 
J Clin Oncol. 2017 Dec 20.
Soiffer RJ (DFCI), Kim HT (DFCI), McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD (BIDMC), Martin PJ, Pidala JA, Lewis ID, Ho VT (DFCI), Alyea EP (DFCI), Ritz J(DFCI), Glavin F, Westervelt P, Jagasia MH, Chen YB (MGH).
PMID: 29040031

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
Nat Commun. 2017 Dec 19.
Liu D, Abbosh P, Keliher D, Reardon B, Miao D, Mouw K (DFCI), Weiner-Taylor A, Wankowicz S, Han G, Teo MY, Cipolla C, Kim J, Iyer G, Al-Ahmadie H, Dulaimi E, Chen DYT, Alpaugh RK, Hoffman-Censits J, Garraway LA (DFCI), Getz G (MGH), Carter SL (DFCI), Bellmunt J (DFCI), Plimack ER, Rosenberg JE, Van Allen EM (DFCI).
PMCID: PMC5736752

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy. 
Nat Commun. 2017 Dec 19.
Landau DA, Sun C, Rosebrock D, Herman SEM, Fein J, Sivina M, Underbayev C, Liu D, Hoellenriegel J, Ravichandran S, Farooqui MZH, Zhang W, Cibulskis C, Zviran A, Neuberg DS (DFCI), Livitz D, Bozic I, Leshchiner I, Getz G (MGH), Burger JA, Wiestner A, Wu CJ (DFCI).
PMCID: PMC5736707

First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study.
Cancer Discov. 2017 Dec 15.
Sullivan RJ (MGH), Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI (DFCI), Mier JW (BIDMC), Tolcher AW, Wang-Gillam A, Sznol M, Flaherty K (MGH), Buchbinder E (DFCI), Carvajal RD, Varghese AM, Lacouture ME, Ribas A, Patel SP, DeCrescenzo GA, Emery CM, Groover AL, Saha S, Varterasian M, Welsch DJ, Hyman DM, Li BT.
PMID: 29247021

The Impact of Smoking and TP53 mutations in lung adenocarcinoma patients with targetable mutations - the Lung Cancer Mutation Consortium (LCMC2).
Clin Cancer Res. 2017 Dec 7.
Aisner DL, Sholl LM (BWH), Berry L, Rossi M, Chen H, Fujimoto J, Moreira AL, Ramalingam S, Villaruz LC, Otterson GA, Haura EB, Politi K, Glisson BS, Cetnar J, Garon E, Schiller J, Waqar S, Sequist LV (MGH), Brahmer JR, Shyr Y, Kugler K, Wistuba II, Johnson BE (DFCI), Minna JD, Kris MG, Bunn PA, Kwiatkowski DJ (BWH).
PMID: 29217530

Aging and neurodegeneration are associated with increased mutations in single human neurons.
Science. 2017 Dec 7.
Lodato MA, Rodin RE, Bohrson CL, Coulter ME, Barton AR, Kwon M, Sherman MA, Vitzthum CM, Luquette LJ, Yandava C, Yang P, Chittenden TW, Hatem NE, Ryu SC, Woodworth MB, Park PJ (HMS), Walsh CA (BCH).
PMID: 29217584